Americans for Safe Access has created a series of publications to help medical cannabis stakeholders navigate the medical, legal, and political aspects of cannabis.
Regulating Patient Health
In this comprehensive report we meticulously examine the existing disparities between cannabis testing programs across the states as they relate to other regulated products, with a particular focus on their impact on patient health. Our aim is to ...
2022 State of States report
Each year, Americans for Safe Access, the nation’s largest nonprofit that represents medical cannabis patients, doctors, and researchers, prepares a report that assesses legislative and regulatory improvements in medical cannabis programs across t...
Cannabis and Cannabis Resin- Critical Review Preparation ...
A review of Medical Cannabis by ASA's 2016 National Medical Cannabis Unity Conference for presentation to the United Nations Special Assembly
Scheduling Cannabis: A Preparatory Document for FDA’s 8-...
The 8-Factor analysis is a guide for addressing the DEA's requirements for rescheduling and regulating Cannabis as a safe and effective medicine.
The DEA’s Denial of Existing Medical Cannabis Research
This report attempts to correct errors present in the DEA's argument on why not to reschedule cannabis
What's the Cost? The Federal War on Patients
Our research found that the federal government spent nearly $500 million on raids, federal prosecutions, incarceration, and asset forfeiture suits related to medical marijuana.
A Viable Strategy to Address the Opioid Crisis
A viable strategy to address the opioid crisis utilizing medical cannabis
Medical Cannabis as a Tool to Combat Pain and Opioid Crisis
Using medical cannabis to treat chronic pain is supported by research and medical professionals, and has demonstrated positive public health outcomes.
Reports Archive
Our old reports
Guides to Using Medical Cannabis
Share this page
